Your browser doesn't support javascript.
loading
Targeting benign prostate hyperplasia treatments: AR/TGF-ß/NOX4 inhibition by apocynin suppresses inflammation and proliferation.
Jin, Bo-Ram; Kim, Hyo-Jung; Na, Jung-Hyun; Lee, Won-Kyu; An, Hyo-Jin.
Affiliation
  • Jin BR; Department of Oriental Pharmaceutical Science, College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea. Electronic address: wlsqh92@khu.ac.kr.
  • Kim HJ; Department of Oriental Pharmaceutical Science, College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea. Electronic address: hyojung_95@khu.ac.kr.
  • Na JH; School of Biopharmaceutical and Medical Sciences, Sungshin Women's University, Seoul, Republic of Korea. Electronic address: jhna@sungshin.ac.kr.
  • Lee WK; New Drug Development Center, Osong Medical Innovation Foundation, Cheongju, Chungcheongbuk-do, 28160, Republic of Korea. Electronic address: gre7@kbiohealth.kr.
  • An HJ; Department of Oriental Pharmaceutical Science, College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea; Department of Integrated Drug Development and Natural Products, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea. Electronic address: hjan@khu.ac.kr.
J Adv Res ; 57: 135-147, 2024 Mar.
Article in En | MEDLINE | ID: mdl-37061215

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acetophenones / Prostatic Hyperplasia / Androgens Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: J Adv Res Year: 2024 Document type: Article Country of publication: Egipto

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acetophenones / Prostatic Hyperplasia / Androgens Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: J Adv Res Year: 2024 Document type: Article Country of publication: Egipto